UBS Maintains Buy on Zimmer Biomet Holdings, Raises Price Target to $130

Benzinga · 4d ago
UBS analyst Patrick Wood maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Buy and raises the price target from $120 to $130.